The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.

<h4>Objective</h4>The aim of this study was to evaluate the diagnostic accuracy and efficiency of p16/ki-67 dual stain in the identification of CIN2+ lesions, in Greek women with ASCUS or LSIL cytology.<h4>Methods</h4>A total of 200 women, 20 to 60 years old, were enrolled in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Magkana, Panagiota Mentzelopoulou, Ekaterini Magkana, Andreas Pampanos, Georgios Daskalakis, Ekaterini Domali, Alexandros Rodolakis, Kalliopi Pappa
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/044d9a6f0c864b7e87392b9f9944e3fb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:044d9a6f0c864b7e87392b9f9944e3fb
record_format dspace
spelling oai:doaj.org-article:044d9a6f0c864b7e87392b9f9944e3fb2021-12-02T20:10:44ZThe p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.1932-620310.1371/journal.pone.0253045https://doaj.org/article/044d9a6f0c864b7e87392b9f9944e3fb2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0253045https://doaj.org/toc/1932-6203<h4>Objective</h4>The aim of this study was to evaluate the diagnostic accuracy and efficiency of p16/ki-67 dual stain in the identification of CIN2+ lesions, in Greek women with ASCUS or LSIL cytology.<h4>Methods</h4>A total of 200 women, 20 to 60 years old, were enrolled in the study. All samples were cytologically evaluated and performed for p16/ki-67 and high-risk HPV (HR-HPV) test. All patients were referred to colposcopy for biopsy and histological evaluation. Three cervical cancer (CC) screening strategies were designed and the total direct medical costs of the procedures during our clinical trial were evaluated, from a healthcare perspective.<h4>Results</h4>HPV 16 as expected was the most common HR-HPV type followed by HPV 31 and HPV 51. The risk for CIN2+ was significantly higher in HPV 16/18 positive cases. p16/ki-67 demonstrated a high sensitivity for CIN2+ identification in both ASCUS and LSIL groups (90.4% and 95%, respectively). HR-HPV test with sensitivity 52.3% and 65.5%, as well as colposcopy with sensitivity 14.3% and 36% respectively in ASCUS and LSIL group, showed inferior results compared to p16/ki-67. The specificity of p16/ki-67 for ASCUS and LSIL was 97.2% and 95.2% respectively, inferior only to colposcopy: 100% and 100%, lacking however statistical significance. HR-HPV test instead, presented the lowest specificity: 76.4% and 71.4% respectively in comparison to the other two methods. From a healthcare perspective, the costs and benefits of the tests implementation for the annual screening and triaging, in three CC screening strategies, were also calculated and discussed.<h4>Conclusions</h4>The results of the study indicate that p16/ki-67 is a safe and rapid assay that could be used to detect CIN2+ among women with mild cervical lesions, presenting both high sensitivity and specificity and could minimize the psychological and economic burden of HPV screening.Maria MagkanaPanagiota MentzelopoulouEkaterini MagkanaAndreas PampanosGeorgios DaskalakisEkaterini DomaliAlexandros RodolakisKalliopi PappaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0253045 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Maria Magkana
Panagiota Mentzelopoulou
Ekaterini Magkana
Andreas Pampanos
Georgios Daskalakis
Ekaterini Domali
Alexandros Rodolakis
Kalliopi Pappa
The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
description <h4>Objective</h4>The aim of this study was to evaluate the diagnostic accuracy and efficiency of p16/ki-67 dual stain in the identification of CIN2+ lesions, in Greek women with ASCUS or LSIL cytology.<h4>Methods</h4>A total of 200 women, 20 to 60 years old, were enrolled in the study. All samples were cytologically evaluated and performed for p16/ki-67 and high-risk HPV (HR-HPV) test. All patients were referred to colposcopy for biopsy and histological evaluation. Three cervical cancer (CC) screening strategies were designed and the total direct medical costs of the procedures during our clinical trial were evaluated, from a healthcare perspective.<h4>Results</h4>HPV 16 as expected was the most common HR-HPV type followed by HPV 31 and HPV 51. The risk for CIN2+ was significantly higher in HPV 16/18 positive cases. p16/ki-67 demonstrated a high sensitivity for CIN2+ identification in both ASCUS and LSIL groups (90.4% and 95%, respectively). HR-HPV test with sensitivity 52.3% and 65.5%, as well as colposcopy with sensitivity 14.3% and 36% respectively in ASCUS and LSIL group, showed inferior results compared to p16/ki-67. The specificity of p16/ki-67 for ASCUS and LSIL was 97.2% and 95.2% respectively, inferior only to colposcopy: 100% and 100%, lacking however statistical significance. HR-HPV test instead, presented the lowest specificity: 76.4% and 71.4% respectively in comparison to the other two methods. From a healthcare perspective, the costs and benefits of the tests implementation for the annual screening and triaging, in three CC screening strategies, were also calculated and discussed.<h4>Conclusions</h4>The results of the study indicate that p16/ki-67 is a safe and rapid assay that could be used to detect CIN2+ among women with mild cervical lesions, presenting both high sensitivity and specificity and could minimize the psychological and economic burden of HPV screening.
format article
author Maria Magkana
Panagiota Mentzelopoulou
Ekaterini Magkana
Andreas Pampanos
Georgios Daskalakis
Ekaterini Domali
Alexandros Rodolakis
Kalliopi Pappa
author_facet Maria Magkana
Panagiota Mentzelopoulou
Ekaterini Magkana
Andreas Pampanos
Georgios Daskalakis
Ekaterini Domali
Alexandros Rodolakis
Kalliopi Pappa
author_sort Maria Magkana
title The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
title_short The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
title_full The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
title_fullStr The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
title_full_unstemmed The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
title_sort p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/044d9a6f0c864b7e87392b9f9944e3fb
work_keys_str_mv AT mariamagkana thep16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT panagiotamentzelopoulou thep16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT ekaterinimagkana thep16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT andreaspampanos thep16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT georgiosdaskalakis thep16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT ekaterinidomali thep16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT alexandrosrodolakis thep16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT kalliopipappa thep16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT mariamagkana p16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT panagiotamentzelopoulou p16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT ekaterinimagkana p16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT andreaspampanos p16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT georgiosdaskalakis p16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT ekaterinidomali p16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT alexandrosrodolakis p16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
AT kalliopipappa p16ki67assayisasafeeffectiveandrapidapproachtotriagewomenwithmildcervicallesions
_version_ 1718374924234522624